HART RONALD W 4

Accession 0001121781-12-000221

CIK 0000924515other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 5:41 PM ET

Size

29.9 KB

Accession

0001121781-12-000221

Insider Transaction Report

Form 4

Period: 2012-07-06

GUIDED THERAPEUTICS INCGTHP

HART RONALD W

Director

Transactions

Exercise/Conversion
Common Stock
2012-06-15$0.40/sh+21,522$8,609→ 711,060 total
Exercise/Conversion
Common Stock Warrants (Right to Buy)
2012-06-15−21,522→ 0 total
Exercise: $0.40From: 2012-07-05Exp: 2012-09-15→ Common Stock (21,522 underlying)
Exercise/Conversion
Common Stock
2012-06-15$0.40/sh+57,282$22,913→ 265,019 total(indirect: By Hart Management)
Disposition to Issuer
Common Stock Warrants (Right to Buy)
2012-06-15−64,564→ 0 total
Exercise: $0.65Exp: 2013-03-01→ Common Stock (64,564 underlying)
Award
Common Stock Warrants (Right to Buy)
2012-07-06+21,522→ 21,522 total
Exercise: $0.65From: 2012-07-05Exp: 2014-03-01→ Common Stock (21,522 underlying)
Award
Common Stock Warrants (Right to Buy)
2012-07-06+21,520→ 21,520 total
Exercise: $0.80From: 2012-07-05Exp: 2014-03-01→ Common Stock (21,520 underlying)
Award
Common Stock Warrants (Right to Buy)
2012-06-15+51,282→ 51,282 total(indirect: by Hart Management)
From: 2012-07-05Exp: 2012-09-15→ Common Stock (51,282 underlying)
Award
Common Stock Warrants (Right to Buy)
2012-07-06+51,282→ 51,282 total(indirect: by Hart Management)
Exercise: $0.65From: 2012-07-05Exp: 2014-03-01→ Common Stock (51,282 underlying)
Award
Common Stock Warrants (Right to Buy)
2012-07-06+51,282→ 51,282 total(indirect: by Hart Management)
Exercise: $0.80From: 2012-07-05Exp: 2015-03-01→ Common Stock (51,282 underlying)
Exercise/Conversion
Common Stock Warrants (Right to Buy)
2012-06-15−51,282→ 0 total(indirect: by Hart Management)
Exercise: $0.40From: 2012-07-05Exp: 2012-09-15→ Common Stock (51,282 underlying)
Disposition to Issuer
Common Stock Warrants (Right to Buy)
2012-06-15−153,846→ 0 total(indirect: by Hart Management)
Exercise: $0.65From: 2007-03-01Exp: 2013-03-01→ Common Stock (153,846 underlying)
Award
Common Stock Warrants (Right to Buy)
2012-06-15+21,522→ 21,522 total
From: 2012-07-05Exp: 2012-07-15→ Common Stock (21,522 underlying)

Footnotes (4)

[F1]The securities were immediately exercisable upon issuance, and were issued on either 12/1/2008 or 8/31/2009.
[F2]Effective July 6, 2012, the issuer conceled, pursuant to its warrant exchange offer, warrants to purchase an aggregate of 218,410 shares of the issuer's common stock, granted to the reporting person on 3/1/2007, 12/1/2008, or 8/31/2009. In exchange, the reporting person received a combination of three types of new warrants with varying exercise prices and expiration dates, exercisable for an aggretate of 218,410 shares of the issuer's common stock.
[F3]Dr. Hart is the owner and CEO of Hart Management, LLC.
[F4]The security had three different exercise prices, depending on the time exercised, ranging from $.40 to $.50 per share. When exercised, the exercise price was $.40 per share.

Documents

1 file

4
rhartfm47612.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

GUIDED THERAPEUTICS INC

CIK 0000924515

→

Entity typeother

Related Parties

filerCIK 0001388125

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 5:41 PM ET
Size: 29.9 KB

View on SEC.gov